...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Bear

All I can say right now is that it wasn't me. I don't have time to look into this right now. You can PM the other two Zenith hub leaders (Toinv, San Fran), but neither is very active right now on the board so unlikely to be them in my opinion. Did you check with Dutchfella? That might be the best place to start!

BDAZ

Share
New Message
Please login to post a reply